Institutional & Family Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Institutional & Family Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-35	Closed	-$2K	–	919
2019 Q3	$2K	Hold	35	–	–	﹤0.01%	753
2019 Q2	$2K	Hold	35	–	–	﹤0.01%	767
2019 Q1	$2K	Hold	35	–	–	﹤0.01%	756
2018 Q4	$2K	Hold	35	–	–	﹤0.01%	732
2018 Q3	$2K	Hold	35	–	–	﹤0.01%	775
2018 Q2	$2K	Hold	35	–	–	﹤0.01%	759
2018 Q1	$1K	Buy	+35	New	+$1.16K	﹤0.01%	833

Institutional & Family Asset Management's GHDX Position: Q4 2019 in Review

Institutional & Family Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 35 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in GHDX in Q1 2018 and held it in 7 quarters. The position peaked at $2K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Institutional & Family Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Institutional & Family Asset Management sold 35 Genomic Health, Inc. shares in Q4 2019, an estimated $2K.
Institutional & Family Asset Management first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 7 quarters.
Institutional & Family Asset Management's Genomic Health, Inc. position peaked at $2K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Institutional & Family Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.